STOCK TITAN

Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Natera, Inc. (NTRA) to release Q4 and year-end 2023 financial results on Feb. 28, 2024. Conference call and webcast to follow. Details provided for investors and traders.
Positive
  • None.
Negative
  • None.

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its fourth quarter and year ended December 31, 2023, after the market close on Feb. 28, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information:

Event:

Natera’s Fourth Quarter and Year-End 2023 Financial Results

Date:

Wednesday, Feb. 28, 2024

Time:

1:30 p.m. PT (4:30 p.m. ET)

Live Dial-In:

 

1 (888) 770-7321 (Domestic)
1 (929) 201-7107 (International)

Conference ID:

7684785

Webcast:

https://events.q4inc.com/attendee/656023681

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 180 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com

Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Source: Natera, Inc.

Natera, Inc. (NTRA) will release its Q4 and year-end 2023 financial results on Feb. 28, 2024, after the market close.

The conference call and webcast for Natera, Inc. (NTRA)'s financial results will take place at 1:30 p.m. PT (4:30 p.m. ET) on Feb. 28, 2024.

Investors can access the live webcast for Natera, Inc. (NTRA)'s financial results through the following link: https://events.q4inc.com/attendee/656023681
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

Medical Laboratories
Health Care and Social Assistance
Link
Health Technology, Biotechnology, Health Services, Medical/Nursing Services, Health Care and Social Assistance, Medical Laboratories

About NTRA

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the